Actively Recruiting

Phase 1
Age: 18Years +
All Genders
NCT06083896

Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome

Led by M.D. Anderson Cancer Center · Updated on 2026-03-02

50

Participants Needed

1

Research Sites

273 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Determine whether patients exhibit early functional improvement after minimally-invasive placement of Illuminoss photodynamic nails for peri-acetabular pelvic metastasis at 3 months following procedure

CONDITIONS

Official Title

Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients must have a histologically confirmed malignancy from prior biopsy of the primary tumor or a metastatic site, including carcinoma, myeloma, or lymphoma.
  • Metastatic involvement must be visible radiographically in the periacetabular pelvic region.
  • Patients must be 18 years of age or older.
  • Suitable candidate for general anesthesia.
  • Ability to understand and willingness to sign informed consent.
  • Able and willing to complete pre-operative and post-operative functional outcome surveys.
  • Absolute neutrophil count of at least 1,500/mcL.
  • Platelet count of at least 50,000/mcL.
Not Eligible

You will not qualify if you...

  • Patients with uncontrolled intercurrent illness that significantly increases anesthesia risk, such as recent pneumonia or myocardial infarction.
  • Pregnant women due to risks from general anesthesia and radiation exposure.
  • History of allergic reactions to compounds similar to dental resins or PET.
  • Patients with psychiatric illness or social situations limiting compliance with study requirements.
  • HIV-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

MD Anderson Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

P

Patrick Lin, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here